Member Info for Willy88

Hi..how do you know this?? Re financial year and Qtr 1 and ourcome of the Strategic Review??

Where can i find the Zeus re-rate?

Where can i find the Zeus re-rate?

It's not rising Viking because you and others sold. You've answered your own question!!

Yes Mauv...got all that but still can't see anything here about us having been led to believe.... 'a deal has been done and a set price fixed'. ....

Ploppy..if you read the RNS then you would understand that no dillution took place today. The 100m shares are not being sold at this time. If you further understand where we are as a Cothen new shares are required going forward. Looking at the share dealing then no big money is coming in or going out as the bigger invester will require sight of a MRE. It all starts from then. Sellers here are probably investing in SML at the mo as their MRE is due on Thursday!

Hi Mav...sorry but yes, I noted 'so we are led to believe'. However, my question is where was this information? I.e. led to believe, by whom, when? Just confused. I've not seen anything from a credible source suggesting that a deal has been done and a price set?

Thats not how to claculate it as other costs will increase too...

Mav. Can you please elaborate..'deal has been done and price fixed'? Must have missed that one.....

I think suggesting that the recent investor's 4.7m requiring 10 x upside is a little OTT and I wonder how many here understand early investments in mining. Much of the upside here, until a revised MRE is posted, is built in to the current SP albeit there is some growth if Tungsten prices hold up. There is quite a way to go and many things to consider, least of all final extraction costs & timelines. Regulation is not an easy hurdle either and just because it waz a mine prior and received a government grant, it does not guarantee rapid planning & permitting consent going forward.

Interesting article in Telegraph today focusing on Tungsten...page 19. China now impossing export restrictions. These guys produce more than 80% of global Tungsten supplies.

Interesting article in Telegraph today focusing on Tungsten...page 19. China now impossing export restrictions. These guys produce more than 20% of global Tungsten supplies.

Available on IG

Can someone please claify? ...in final stages of contract with MOD??

Re The Strategic Turnaround. Could you kindly substantantiate point 2?. I'm interested to understand more!.

Pretty impressive podcast numbers so sure to drive the SP lower...lol.

Yer, and I read the moon was made of cheese!!.. sorry, but a silly post really....

A decent post Tennent. There was an old saying back in the 1980's that suggested 'nobody was ever sacked for buying IBM'. Although this is a somewhat stretched comparrison it does support that governments will generally place supply guarantee and track record above price. The LTC was too early for AFC. Also, having such a low price per kg can sometimes plant caution in a purchasers mind as nobody in government wants to buy a polyester suit. Not suggesting AFC is not credible, however it needs to win a few contracts and be seen to be working.

Many jumped in here on the back of Covid and the Co.panies hype about helping to control the virus. Thats was a long shot and TILS at it was then did what many pharma Co's did at the time. However, leading on from this one neexs to understand drug development and its trial timelines, and what happens in between. If the SP is going to do anythi g pisitive it will be in the next few months. Remdmber, they just sold a load of new shares to their close mates at a discount and promised the ability for them to purchase more cheap shares in a few months. Thats was not cricket and I sent a note to the board expressing UK shareholders dissatisfaction. Unfortunately, it fell on deaf ears and the response was unacceptable. Nonetheless, the outcome of both drugs looks positive though Gabrielle wants to hive off the secondary drug under a new listing. Beware!! All UK shareholders should be writing to NASDAQ expressing their concerns at being omitted from the recent capital call. It was out of order given the history of the Company and its previous UK listing.

So why do you invest in R&D pharma if you do not understand the timelines, clinical trials etc?